Rate My Professor Jonathan Sturm

Jonathan Sturm serves as Conjoint Associate Professor in the School of Medicine and Public Health, College of Health, Medicine and Wellbeing, at the University of Newcastle, Australia. He holds the qualifications MBChB, FRACP, and PhD. As a consultant neurologist, he practices at Gosford Hospital and Wyong Hospital within the Central Coast Local Health District. His academic affiliations include the Faculty of Health and Medicine and the Centre for Clinical Epidemiology and Biostatistics at the University of Newcastle. Previously, he has been associated with the Department of Neurology at John Hunter Hospital and the Hunter New England Area Health Service.

Sturm's research specializations encompass stroke epidemiology, psychosocial outcomes, health-related quality of life, sex differences in stroke severity, management, outcomes, and mortality, thrombolysis, genetic factors in ischemic stroke subtypes, and prevention of cardiovascular events through pneumococcal vaccination. He has produced 83 research works garnering 5,569 citations. Notable publications include: "Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke: The EXTEND Trial" (New England Journal of Medicine, 2019); "Sex Differences in Severity of Stroke in the INSTRUCT Study: A Meta-Analysis of Individual Participant Data" (Stroke and Vascular Neurology, 2019); "Sex Differences in Long-Term Quality of Life Among Survivors After Stroke" (Stroke, 2019); "Sex Differences in Long-Term Mortality After Stroke in the International Stroke Outcomes Study" (Circulation: Cardiovascular Quality and Outcomes, 2017); "Shared Genetic Basis for Migraine and Ischemic Stroke" (Neurology, 2015); "Trajectories of Psychological Distress After Stroke" (Annals of Family Medicine, 2012); "Quality of Life After Stroke in a Multiethnic Community" (Stroke, 2004); "Generation of Cardio-Protective Antibodies After Pneumococcal Vaccination" (Atherosclerosis, 2022); "Persistence of Detectable Anti-Pneumococcal Antibodies 4 Years After Vaccination" (Heart, Lung and Circulation, 2024); and "Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine" (JAMA Cardiology, 2025). He received the Brain Foundation Stroke Award in 2008 for research on improving psychosocial outcomes after stroke. His contributions have influenced clinical trials and meta-analyses advancing stroke care and patient recovery strategies.